Home › Funds › CATALYST FINANCIAL PARTNERS LLC › ABBV

CATALYST FINANCIAL PARTNERS LLC position in ABBV

ABBVIE INC · Health Care

CATALYST FINANCIAL PARTNERS LLC reported holding 15,803 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 0.39% of its reported portfolio and ranking #37 among its reported holdings. CATALYST FINANCIAL PARTNERS LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)15.80K sh
Reported value held$4.13M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CATALYST FINANCIAL PARTNERS LLC's ABBV position evolved

CATALYST FINANCIAL PARTNERS LLC first disclosed a stake in ABBV in Q3 2023 at 10,606 shares (US$1.6M). The position peaked in Q3 2026 at 15,803 shares, worth US$4.1M. Across 13 filings, CATALYST FINANCIAL PARTNERS LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 15,803 shares valued at US$4.1M — an increase of 410 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 10.61K $1.58M New
Q4 2023 10.90K $1.69M Add
Q1 2024 11.22K $1.84M Add
Q2 2024 12.30K $2.11M Add
Q3 2024 12.47K $2.46M Add
Q4 2024 12.83K $2.28M Add
Q1 2025 13.34K $2.79M Add
Q2 2025 13.18K $2.45M Reduce
Q3 2025 13.45K $3.11M Add
Q4 2025 14.23K $3.25M Add
Q1 2026 16.33K $3.55M Add
Q2 2026 15.39K $3.87M Reduce
Q3 2026 15.80K $4.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has CATALYST FINANCIAL PARTNERS LLC held ABBV?

CATALYST FINANCIAL PARTNERS LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CATALYST FINANCIAL PARTNERS LLC's current position in ABBV?

As of Q3 2026, CATALYST FINANCIAL PARTNERS LLC holds 15.80K shares of ABBV (ABBVIE INC), valued at $4.13M, representing 0.39% of its reported portfolio and ranking #37.

Has CATALYST FINANCIAL PARTNERS LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), CATALYST FINANCIAL PARTNERS LLC increased its position in ABBV. The position peaked in Q3 2026 at 15.80K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.